MSH2 and lung adenocarcinoma: Interestingly, reduced expression of MSH2 or MLH1 genes has been observed in over 50% of lung adenocarcinomas, and was correlated with decreased overall survival due to increases in MSI and a generalized “mutator” phenotype 8–10.